HBox, a leading virtual care platform, received a strategic investment from Charlesbank Technology Opportunities Fund to enhance its offerings in chronic disease management.

Information on the Target

HBox, a leading virtual care platform tailored for specialty practices, has recently announced a strategic growth investment from the Charlesbank Technology Opportunities Fund II. With the increasing prevalence of chronic diseases and a growing focus on reimbursement for outcome-oriented virtual care, specialty practices are actively seeking innovative solutions to extend patient care beyond traditional in-clinic visits. The investment is geared towards advancing HBox’s virtual care capabilities and furthering its mission to revolutionize care delivery for patients with high-risk chronic conditions.

Founded by BanuPrasad Dhanakoti, Sandeep Subramanya, and Mohammed Ali, HBox integrates cutting-edge, AI-powered technology with connected medical devices and patient-engagement tools. This unique combination enables specialties such as cardiology, pulmonology, and nephrology to create a seamless virtual care environment that continues patient treatment outside traditional clinical settings. HBox’s innovative platform aggregates real-time patient data and clinical documentation, allowing healthcare providers to effectively manage chronic conditions while delivering personalized care.

Industry Overview in the Target's Specific Country

The healthcare technology sector is rapidly evolving, particularly in response to the rising demand for virtual care solutions in the United States. With increasing numbers of patients requiring ongoing management for chronic diseases, healthcare providers are recognizing